The intravascular contrast agent Clariscan (NC 100150 injection) for 3D MR coronary angiography in patients with coronary artery disease

MAGMA. 2000 Nov;11(1-2):65-7. doi: 10.1007/BF02678498.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study

MeSH terms

  • Contrast Media*
  • Coronary Disease / diagnosis*
  • Dextrans
  • Ferrosoferric Oxide
  • Humans
  • Image Processing, Computer-Assisted / methods
  • Iron*
  • Magnetic Resonance Angiography / methods*
  • Magnetite Nanoparticles
  • Oxides*

Substances

  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • Oxides
  • ferumoxtran-10
  • Iron
  • Ferrosoferric Oxide